RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 12.21
-0.54 (-4.24%)
Mar 26, 2026, 4:10 PM GMT
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 7.91 million as of March 26, 2026. Its market cap has increased by 2.00% in one year.
Market Cap
7.91M
Enterprise Value
5.50M
Revenue
4.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.21
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 7.91M, a decrease of -66.78%. That is a compound annual growth rate of -3.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 7.91M | -8.93% |
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.10B |
| GSK plc | 82.14B |
| Haleon | 32.59B |
| Smith & Nephew | 10.28B |
| Genflow Biosciences | 9.91M |
| Oxford BioDynamics | 9.01M |
| Cizzle Biotechnology Holdings | 8.92M |
| Verici Dx | 7.95M |